UK Markets closed

Eurobio Scientific Société anonyme (ALERS.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
20.04+0.39 (+1.98%)
At close: 05:35PM CEST
Full screen
Previous close19.65
Open20.00
Bid0.00 x 0
Ask0.00 x 0
Day's range19.92 - 20.38
52-week range16.52 - 29.76
Volume30,850
Avg. volume48,460
Market cap227.318M
Beta (5Y monthly)-0.50
PE ratio (TTM)2.80
EPS (TTM)7.15
Earnings date12 Oct 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est39.00
  • Globe Newswire

    Eurobio Scientific launches 2 new proprietary tests for the diagnosis of new variants of SARS-CoV-2 and Monkeypox

    Eurobio Scientific launches 2 new proprietary tests for the diagnosis of new variants of SARS-CoV-2 and Monkeypox EBX048 : a routine COVID screening test that simultaneously detects and identifies the presence of Omicron BA.1, Omicron BA.2 and Omicron BA.4/BA.5EBX060 : routine viral test for the differential diagnosis of simian pox, varicella and measles viruses First French test for screening of Omicron BA.4/BA.5 variants or of the 3 viruses including simian pox, requiring only one reaction and

  • Globe Newswire

    Eurobio Scientific expands into Benelux by acquiring the diagnostic company Biomedical Diagnostics NV

    Eurobio Scientific expands into Benelux by acquiring the diagnostic company Biomedical Diagnostics NV Paris, June 13, 2022 –5:45 pm Eurobio Scientific (FR0013240934, ALERS, eligible PEA-PME), a leading French group in the field of specialty in vitro medical diagnostics, announces the acquisition of 100% of the share capital of Biomedical Diagnostics NV (“BMD”), a Belgian company specializing in the distribution of in vitro diagnostic tests in Benelux (Belgium, the Netherlands and Luxembourg). BM

  • Globe Newswire

    EUROBIO SCIENTIFIC: CLOSING OF THE STRATEGIC PARTNERSHIP WITH NEXTSTAGE AM

    CLOSING OF THE STRATEGIC PARTNERSHIP WITH NEXTSTAGE AM EurobioNext holding becomes Eurobio Scientific’s new reference shareholder with a 28.3% holdingThe « Pépites et Territoires » by AXA France investment program and NextStage (NEXTS) own 43.5% of EurobioNextOperation based on a unit price of 25.28 euros per Eurobio Scientific share Paris, May 18, 2022 – 18:30pm Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in vitro medical diagnostics and life sciences,